非生物型人工肝治疗肝衰竭的临床应用现状及进展
Clinical Application Status and Progress of Abiotic Artificial Liver in the Treatment of Liver Failure
DOI: 10.12677/ACM.2022.12101332, PDF,   
作者: 吴 妍:青海大学研究生院,青海 西宁;张 斌*:青海省人民医院急诊ICU,青海 西宁
关键词: 非生物型人工肝;肝衰竭;应用现状;进展;Abiotic Artificial Liver; Liver Failure; Application Status; Progress
摘要: 非生物型人工肝在肝衰竭的临床救治中已得到一定肯定,本文综述不同非生物型人工肝模式的机制及目前临床应用现状,总结各人工肝模式的研究进展、抗凝方案的选择及对未来进一步探索的展望。
Abstract: Abiotic artificial liver has been recognized in the clinical treatment of liver failure. This article re-views the mechanism and current clinical application status of different abiotic artificial liver mod-els, summarizes the research progress of each artificial liver model, the selection of anticoagulant protocols and prospects for further exploration in the future.
文章引用:吴妍, 张斌. 非生物型人工肝治疗肝衰竭的临床应用现状及进展[J]. 临床医学进展, 2022, 12(10): 9208-9213. https://doi.org/10.12677/ACM.2022.12101332

参考文献

[1] 肝衰竭诊治指南(2018年版) [J]. 实用肝脏病杂志, 2019, 22(2): 164-171.
[2] 非生物型人工肝治疗肝衰竭指南(2016年版) [J]. 中华临床感染病杂志, 2016, 9(2): 97-103.
[3] Ogawa, T., Yoshino, H., Sasaki, Y., et al. (2018) Our Approaches to Selective Plasma Exchange. Contributions to Nephrology, 196, 194-199. [Google Scholar] [CrossRef] [PubMed]
[4] Ohkubo, A. and Okado, T. (2017) Selective Plasma Exchange. Transfu-sion and Apheresis Science, 56, 657-660. [Google Scholar] [CrossRef] [PubMed]
[5] 严丽军, 徐立新. 人工肝选择性血浆置换治疗慢加亚急性肝衰竭及费效比分析[J]. 肝脏, 2018, 23(4): 361-362.
[6] Tan, E.X., Wang, M.X., Pang, J., et al. (2020) Plasma Ex-change in Patients with Acute and Acute-on-Chronic Liver Failure: A Systematic Review. World Journal of Gastroen-terology, 26, 219-245. [Google Scholar] [CrossRef] [PubMed]
[7] Kim, J.E., Chun, S., Sinn, D.H., et al. (2021) Initial Experience with High-Volume Plasma Exchange in Patients with Acute Liver Failure. Journal of Clinical Apheresis, 36, 379-389. [Google Scholar] [CrossRef] [PubMed]
[8] Khamri, W., Abeles, R.D., Hou, T.Z., et al. (2017) Increased Expression of Cytotoxic T-Lymphocyte-Associated Protein 4 by T Cells, Induced by B7 in Sera, Reduces Adaptive Immunity in Pa-tients with Acute Liver Failure. Gastroenterology, 153, 263-276. [Google Scholar] [CrossRef] [PubMed]
[9] Bauer, P.R., Ostermann, M., Russell, L., et al. (2022) Plasma Exchange in the Intensive Care Unit: A Narrative Review. Intensive Care Medicine, 48, 1382-1396.
[10] Larsen, F.S. (2019) Artificial Liver Support in Acute and Acute-on-Chronic Liver Failure. Current Opinion in Critical Care, 25, 187-191. [Google Scholar] [CrossRef] 
[11] Gilg, S., Sparrelid, E., Saraste, L., et al. (2018) The Molecular Adsorbent Recirculating System in Posthepatectomy Liver Failure: Results from a Prospective Phase I Study. Hepatology Communications, 2, 445-454. [Google Scholar] [CrossRef] [PubMed]
[12] Sparrelid, E., Gilg, S. and van Gulik, T.M. (2020) Systematic Review of MARS Treatment in Post-Hepatectomy Liver Failure. HPB (Oxford), 22, 950-960. [Google Scholar] [CrossRef] [PubMed]
[13] Tandon, R. and Froghi, S. (2021) Artificial Liver Support Systems. Journal of Gastroenterology and Hepatology, 36, 1164-1179. [Google Scholar] [CrossRef] [PubMed]
[14] Schmuck, R.B., Nawrot, G.H., Fikatas, P., et al. (2017) Single Pass Albumin Dialysis-A Dose-Finding Study to Define Optimal Albumin Concentration and Dialysate Flow. Artificial Organs, 41, 153-161. [Google Scholar] [CrossRef] [PubMed]
[15] Yan, G.S., Li, L.L., Jiang, S.L., et al. (2019) Clinical Study of Different Adsorbents with Dual Plasma Molecular Adsorption System in the Treatment of Hepatic Failure. Chinese Journal of Hepatology, 27, 51-55.
[16] Lei, Y., Liang, Y., Zhang, X., et al. (2021) Alternating Therapeutic Plasma Exchange (TPE) with Double Plasma Molecular Adsorption System (DPMAS) for the Treatment of Fulminant Hepatic Failure (FHF). Clinical Case Reports, 9, e5220. [Google Scholar] [CrossRef] [PubMed]
[17] Guo, X., Wu, F., Guo, W., et al. (2020) Comparison of Plasma Exchange, Double Plasma Molecular Adsorption System, and Their Combination in Treating Acute-on-Chronic Liver Failure. Journal of International Medical Research, 48, Article ID: 1220731605. [Google Scholar] [CrossRef] [PubMed]
[18] Yao, J., Li, S., Zhou, L., et al. (2019) Therapeutic Effect of Dou-ble Plasma Molecular Adsorption System and Sequential Half-Dose Plasma Exchange in Patients with HBV-Related Acute-on-Chronic Liver Failure. Journal of Clinical Apheresis, 34, 392-398. [Google Scholar] [CrossRef] [PubMed]
[19] Kong, L.X., Qiu, F., Wang, H.M., et al. (2020) Economic Evaluation of Plasma Exchange Combined with Dual Plasma Adsorption Therapy for Early, Mid and Late Stage Liver Failure. Chinese Journal of Hepatology, 28, 434-440.
[20] Nand, N., Verma, P. and Jain, D. (2019) Comparative Evaluation of Contin-uous Veno-Venous Hemodiafiltration and Continuous Arterio-Venous Hemodiafiltration in Patients of Hepatic Failure and/or Hepatorenal Syndrome. Journal of the Association of Physicians of India, 67, 39-42.
[21] Fujiwara, K., Abe, R., Yasui, S., et al. (2019) High Recovery Rate of Consciousness by High-Volume Filtrate Hemodiafiltration for Fulminant Hepatitis. Hepatology Research, 49, 224-231. [Google Scholar] [CrossRef] [PubMed]
[22] Takikawa, Y., Kakisaka, K., Suzuki, Y., et al. (2021) Multicenter Study on the Consciousness-Regaining Effect of a Newly Developed Artificial Liver Support System in Acute Liver Failure: An On-Line Continuous Hemodiafiltration System. Hepatology Research, 51, 216-226. [Google Scholar] [CrossRef] [PubMed]
[23] Inoue, K. (2021) Newly Developed On-Line Continuous He-modiafiltration for Acute Liver Failure. Hepatology Research, 51, 154-155. [Google Scholar] [CrossRef] [PubMed]
[24] Zhang, Y., Dong, R., Li, Y., et al. (2022) Efficacy and Safety of Plasma Diafiltration: Review of Case Reports and Case Series. Therapeutic Apheresis and Dialysis. [Google Scholar] [CrossRef] [PubMed]
[25] 马元吉, 许艳, 白浪, 等. 肝素钠与枸橼酸钠封管液在人工肝治疗肝衰竭患者的应用比较[J]. 实用肝脏病杂志, 2020, 23(1): 66-69.
[26] Dyla, A., Mielnicki, W., Bartczak, J., et al. (2017) Effectiveness and Safety Assessment of Citrate Anticoagulation during Albumin Dialysis in Comparison to Other Methods of Anticoagulation. Artificial Organs, 41, 818-826. [Google Scholar] [CrossRef] [PubMed]